CA3239989A1 - A pharmaceutical composition for the treatment of otic infections - Google Patents
A pharmaceutical composition for the treatment of otic infections Download PDFInfo
- Publication number
- CA3239989A1 CA3239989A1 CA3239989A CA3239989A CA3239989A1 CA 3239989 A1 CA3239989 A1 CA 3239989A1 CA 3239989 A CA3239989 A CA 3239989A CA 3239989 A CA3239989 A CA 3239989A CA 3239989 A1 CA3239989 A1 CA 3239989A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- gentamicin
- pharmaceutically acceptable
- posaconazole
- mometasone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291673P | 2021-12-20 | 2021-12-20 | |
| US63/291,673 | 2021-12-20 | ||
| PCT/EP2022/086649 WO2023117900A1 (en) | 2021-12-20 | 2022-12-19 | A pharmaceutical composition for the treatment of otic infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3239989A1 true CA3239989A1 (en) | 2023-06-29 |
Family
ID=84942883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3239989A Pending CA3239989A1 (en) | 2021-12-20 | 2022-12-19 | A pharmaceutical composition for the treatment of otic infections |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049827A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4452269B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024547035A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118434420A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022421489A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239989A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3050117T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007632A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023117900A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2576589C (en) | 2004-08-13 | 2013-11-12 | Schering-Plough Ltd. | Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid |
-
2022
- 2022-12-19 CN CN202280084383.8A patent/CN118434420A/zh active Pending
- 2022-12-19 US US18/720,093 patent/US20250049827A1/en active Pending
- 2022-12-19 MX MX2024007632A patent/MX2024007632A/es unknown
- 2022-12-19 WO PCT/EP2022/086649 patent/WO2023117900A1/en not_active Ceased
- 2022-12-19 AU AU2022421489A patent/AU2022421489A1/en active Pending
- 2022-12-19 ES ES22843140T patent/ES3050117T3/es active Active
- 2022-12-19 EP EP22843140.9A patent/EP4452269B1/en active Active
- 2022-12-19 CA CA3239989A patent/CA3239989A1/en active Pending
- 2022-12-19 JP JP2024536463A patent/JP2024547035A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4452269B1 (en) | 2025-09-03 |
| EP4452269A1 (en) | 2024-10-30 |
| AU2022421489A1 (en) | 2024-06-06 |
| WO2023117900A1 (en) | 2023-06-29 |
| CN118434420A (zh) | 2024-08-02 |
| MX2024007632A (es) | 2024-07-09 |
| US20250049827A1 (en) | 2025-02-13 |
| JP2024547035A (ja) | 2024-12-26 |
| ES3050117T3 (en) | 2025-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2862406C (en) | Otic formulations, methods and devices | |
| RU2394573C2 (ru) | Фармацевтическая композиция | |
| KR20180017213A (ko) | 포유류에서 내부 및 외부 귀의 감염에 대한 귀 치료용 조성물 | |
| US8895542B2 (en) | Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it | |
| EP4452269B1 (en) | A pharmaceutical composition for the treatment of otic infections | |
| AU2025203598A1 (en) | Novel use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals | |
| CN102083414A (zh) | 包含抗生素和皮质类固醇的组合物 | |
| WO2010106465A1 (en) | A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate | |
| CN110604819A (zh) | 控制释放组合物及其使用方法 | |
| US12491189B2 (en) | OTIC formulations, methods and devices | |
| US20150297588A1 (en) | Sterile otic formulations | |
| US20220401457A1 (en) | Use of Deoxycholic Acid, Derivatives, or Salts Thereof in Managing Bacterial Infections and Compositions Related Thereto | |
| EP4729057A1 (en) | Method of treating disease using compound, and use of compound | |
| WO2020098563A1 (zh) | 含有多肽类化合物的药物组合物及其制备方法和用途 | |
| US11229597B2 (en) | Topical doxycycline composition | |
| CN114306218A (zh) | 满足药学抑菌要求的经粘膜给药r-氯胺酮药物组合物 | |
| CA3153832C (en) | Otic formulations, methods and devices | |
| US20140315871A1 (en) | Topical pharmaceutical compositions of anti-microbial agents and anti-inflammatory agents | |
| WO2010106502A1 (en) | A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it | |
| WO2010106503A1 (en) | A dermaceutical cream made using sodium fusidate, miconazole nitrate and mometasone furoate | |
| WO2012035374A1 (en) | A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate | |
| WO2012035380A1 (en) | A novel dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate, a process to make the same, and a method of treatment using it |